Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Chemical alterations in the brain hint at whether loss of smell will return post-COVID
Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus.
Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
Surgeons make history again with world’s first robotic implant of Abbott heart device
The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.
Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.
Key details associated with the treatment of COVID-induced arrhythmias
Rakesh Gopinathannair, MD, lead author of a recent American Heart Association scientific statement on cardiac arrhythmias associated with COVID-19, reviewed the latest science associated with this important topic.

Redo TAVR is not always a feasible treatment option, researchers explained. TAVR explantation can be offered to a larger patient population.

Low-income countries were hit especially hard by the pandemic.

Parts of the device can move or become loose during procedures, the FDA warned.

The next-generation devices were designed to be used without blood-thinners.

The Food and Drug Administration has approved booster shots of the Pfizer-BioNTech COVID-19 vaccine.

Pfizer and BioNTech are having trouble finding enough participants to enroll in a study of COVID-19 vaccines in expectant mothers.

The COVID-19 pandemic has shaved more than nine million years off aggregate life expectancy in the U.S.

Moving forward with PCI can make a massive difference for STEMI patients, even 48 hours after symptoms first began.